Myotonic Disorders in Childhood: Diagnosis and Treatment

Abstract

The recent discoveries that mutations in the genes for the skeletal muscle sodium and chloride channels are responsible, respectively, for paramyotonia/hyperkalemic periodic paralysis and for myotonia congenita of Thomsen have made the classification, diagnosis, and treatment of these disorders much easier. The discovery that myotonic dystrophy results from an unstable [CTG]_n trinucleotide expansion has permitted the accurate diagnosis of both symptomatic and asymptomatic individuals, and has led to major advances in preventive treatment, including prenatal and genetic counseling. Diseases that resemble the inherited myotonic disorders are now easier to identify, and as a result of genetic testing a new clinical disorder that is similar to but distinct from myotonic dystrophy has emerged. This new disorder, proximal myotonic myopathy, does not appear to be linked to the genes for the sodium or chloride channels, and has cataracts, myotonia, weakness, and no abnormal expansion of the [CTG]_n repeat in the gene for myotonic dystrophy. This review discusses the diagnosis and treatment of these myotonic disorders. (J Child Neurol 1997;12:116-129).

Get full access to this article

View all access options for this article.

References

Ptáček LJ , Johnson KJ , Griggs RC : Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482-489.

Meyer-Kleine C. , Steinmeyer K. , Ricker K. , et al: Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN 1) leading to myotonia. Am J Hum Genet 1995;57:1325-1334.

Trudell RG , Kaiser KK , Griggs RC : Acetazolamide responsive myotonia congenita. Neurology 1987;37:488-491.

Ptáček LJ , Tawil R. , Griggs RC , et al: Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis . Neurology 1994;44:1500-1503.

Lerche H. , Heine R. , Pika U. , et al: Human sodium channel myotonia: Slowed channel inactivation due to substitutions for a glycine within the III-IV linker. J Physiol 1993;470:13-22.

Ricker KW , Moxley RT : Myotonia fluctuans. A third type of muscle sodium channel disease . Ann Neurol 1994;51:1095-1102.

Moxley RT III : Myotonic muscular dystrophy, in Rowland LP (ed): Handbook of Clinical Neurology , vol. 18. Amsterdam, Elsevier, 1992, pp 209-259.

Harper PS : Myotonic Dystrophy, 2nd ed. London, Saunders, 1989.

Thornton CA , Griggs RC , Moxley RT Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994;35:269-272.

10.

Ricker K. , Koch MC , Lehmann-Horn F. , et al: Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994;44:1448-1452.

11.

Ricker K. , Koch MC , Lehmann-Horn F. , et al: Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31.

12.

Moxley RT III: Proximal myotonic myopathy, a recently delineated autosomal dominant disorder. Neuromusc Disord 1996;6:87-93.

13.

Dyken PR , Harper PS : Congenital dystrophia myotonica. Neurology 1973;23:465-473.

14.

Brook JD , McCurrach ME , Harley HG , et al: Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.

15.

Fu YH , Pizzuti A. , Fenwick RG Jr , et al: An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255:1256-1258.

16.

Mahadevan M. , Tsilfidis C. , Sabourin L. , et al: Myotonic dystrophy mutation: An unstable CTG repeat in the 3' untranslated region of the gene . Science 1992;255:1253-1255.

17.

Redman JB , Fenwick RG , Fu YH , et al: Relationship between parental trinucleotide CTG repeat length and severity of myotonic dystrophy in offspring. JAMA 1993;269:1960-1965.

18.

Harley HG , Rundle SA , MacMillan JC , et al: Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52: 1164-1174.

19.

Lavedan C. , Hofmann-Radvanyi H. , Shelbourne P. , et al: Myotonic dystrophy: Size and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993; 52:873-883.

20.

Tsilfidis C. , MacKenzie AE , Mettler G. , et al: Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet 1992;1:192-195.

21.

Shelbourne P. , Davies J. , Buxton J. , et al: Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N Engl J Med 1993;328:471-475.

22.

Rudel R. , Ruppersberg JP , Spittelmeister W. : Abnormalities of the fast sodium current in myotonic dystrophy, recessive generalized myotonia, and adynamia episodica. Muscle Nerve 1989; 12:281-287.

23.

Behrens MI , Jalil P. , Serani A. , et al: Possible role of apamin-sensitive K+ channels in myotonic dystrophy . Muscle Nerve 1994; 17:1264-1270.

24.

Hunter A. , Tsilfidis C. , Mettler G. , et al: The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 1992;29:774-779.

25.

Jansen G. , Willems P. , Coerwinkel M. , et al: Gonosomal mosaicism in myotonic dystrophy patients: Involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet 1994;54:575-585.

26.

Brunner HG , Bruggenwirth HT , Nillesen W. : Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet 1993;58: 1016-1023.

27.

Ashizawa T. , Anvret M. , Baiget M. : Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet 1994;54:414-423.

28.

Ashizawa T. , Dubel JR , Harati Y. : Somatic instability of CTG repeat in myotonic dystrophy. Neurology 1993;43:2674-2678.

29.

Anvret M. , Ahlberg G. , Grandell U. , et al: Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum Mol Genet 1993;2:1397-1400.

30.

Thornton CA , Johnson K. , Moxley RT III: Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leucocytes . Ann Neurol 1994;35:104-107.

31.

Neville CE , Mahadevan MS , Barcelo JM , et al: High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation. Hum Mol Genet 1994;3:45-51.

32.

Lavedan C. , Hofinann-Radvanyi H. , Boileau C. , et al: French myotonic dystrophy families show expansion of a CTG repeat in complete linkage disequilibrium with an intragenic 1 kb insertion. J Med Genet 1994;31:33-36.

33.

Shaw DJ , McCurrach M. , Rundle SA , et al: Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 1993;18:673-679.

34.

Fu YH , Friedman DL , Richards S. , et al: Varying expression of myotonin-protein kinase mRNA and protein levels in the adult form of myotonic dystrophy. Science 1993;72:971-983.

35.

Griggs RC , Pandya S. , Florence JM , et al: Randomized controlled trial of testosterone in myotonic dystrophy . Neurology 1989; 39:219-222.

36.

Thornton CA , Griggs RC , Welle S. , et al: Recombinant human growth hormone (rHGH) treatment increases lean body mass in patients with myotonic dystrophy, abstract . Neurology 1993; 43:A280.

37.

Koch MC , Steinmeyer K. , Lorenz C. , et al: The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257:797-800.

38.

Abdalla JA , Casley WL , Cousin HK , et al: Linkage of Thomsen disease to the T-cell receptor beta (TCRB) locus on chromosome 7q35. Am J Hum Genet 1992 ;51:579-584.

39.

George AL , Crackower MA , Abdalla JA , et al: Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet 1993;3:305-310.

40.

Koch MC , Ricker K. , Otto M. , et al: Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker). J Med Genet 1993;30:914-917.

41.

Koty PP , Marks HG , Turel A. , et al: Linkage and mutation analysis of Thomsen and Becker myotonia families, abstract. Am J Hum Gen 1994;55(Suppl):227.

42.

Streib EW : AAEM Minimonograph #27: Differential diagnosis of myotonic syndromes . Muscle Nerve 1987;10:603-615.

43.

Rüdel R. , Lehmann-Horn F. , Ricker K. : Altered excitability of the muscle cell membrane. The nondystrophic myotonias , in Engel AG , Franzini-Armstrong C (eds): Myology. New York, McGraw-Hill, pp 1291-1302.

44.

Zwarts MJ , VanWeerden TW : Transient paresis in myotonic syndromes. Brain 1989;112:665-680.

45.

Crew J. , Kaiswer KK , Brooke MH : Muscle pathology of myotonia congenita. J Neurol Sci 1976;28:440-457.

46.

Lipicky RJ , Bryant SH : A biophysical study of the human myotonias, in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology. Basel, Switzerland, S Karger , 1993, pp 451-463.

47.

Ricker K. , Lehmann-Horn F. , Moxley RT III: Myotonia fluctuans. Arch Neurol 1990;47:268-272.

48.

Munsat TL : Therapy of myotonia. A double-blind evaluation of diphenylhydantoin, procainamide, and placebo. Neurology 1967; 17:359-367.

49.

Kwiecinski H. , Ryniewicz B. , Ostrzycki A. : Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand 1992;86:371-375.

50.

Ceccarelli M. , Rossi B. , Sicilino G. , et al: Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. Acta Paediatr 1992 ;81:453-455.

51.

Ptáček LJ , Tawil R. , Griggs RC , et al: Linkage of atypical myotonia congenita to a sodium channel locus. Neurology 1992;42: 431-433.

52.

Soff GA , Kadin ME : Tocainide-induced reversible agranulocytosis and anemia. Arch Intern Med 1987;147:598-599.

53.

Plassart E. , Reboul J. , Rime CS , et al: Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: Phenotype to genotype correlations and demonstrations of the predominance of two mutations. Eur J Hum Genet 1994;2:110-124.

54.

Riggs JE , Griggs RC : The diagnosis and treatment of the periodic paralyses, in Klawans HL (ed): Clinical Neuropharmacology , New York, Raven Press, 1979, pp 123-138.

55.

Ptacek LJ , George AL , Griggs RC , et al: Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-1027.

56.

Rojas CV , Wang J. , Schwartz LS , et al: A Met-to-Val mutation in the skeletal muscle Na+ channel α-subunit in hyperkalemic periodic paralysis. Nature 1991;354:387-389.